Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EPZM

Epizyme

$5.94

0.08 (1.37%)

, GSK

GlaxoSmithKline

$37.07

-0.54 (-1.44%)

06:32
12/18/18
12/18
06:32
12/18/18
06:32
Hot Stocks
Epizyme earns $8M milestone payment from GlaxoSmithKline »

Epizyme (EPZM) announced…

EPZM

Epizyme

$5.94

0.08 (1.37%)

GSK

GlaxoSmithKline

$37.07

-0.54 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
EPZM

Epizyme

$7.27

-0.31 (-4.09%)

07:46
11/15/18
11/15
07:46
11/15/18
07:46
Conference/Events
Epizyme to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

EPZM

Epizyme

$7.27

-0.31 (-4.09%)

06:38
11/15/18
11/15
06:38
11/15/18
06:38
Hot Stocks
Epizyme and Boehringer Ingelheim to co-develop novel epigenetic oncology therapy »

Epizyme and Boehringer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$8.40

0.33 (4.09%)

06:36
11/02/18
11/02
06:36
11/02/18
06:36
Hot Stocks
Breaking Hot Stocks news story on Epizyme »

Epizyme sees cash, cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$8.40

0.33 (4.09%)

06:36
11/02/18
11/02
06:36
11/02/18
06:36
Earnings
Epizyme reports Q3 EPS (54c), consensus (61c) »

Reports Q3 revenue $0,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$8.28

-0.48 (-5.48%)

08:29
10/23/18
10/23
08:29
10/23/18
08:29
Recommendations
Epizyme analyst commentary at Roth Capital »

Epizyme price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$8.76

-0.04 (-0.45%)

07:55
10/22/18
10/22
07:55
10/22/18
07:55
Conference/Events
Epizyme to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EPZM

Epizyme

$8.76

-0.04 (-0.45%)

05:56
10/22/18
10/22
05:56
10/22/18
05:56
Hot Stocks
Epizyme says tazemetostat showed clinically meaningful activity in ES patients »

Epizyme announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EPZM

Epizyme

$8.76

-0.04 (-0.45%)

04:55
10/22/18
10/22
04:55
10/22/18
04:55
Conference/Events
Epizyme to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EPZM

Epizyme

$8.76

-0.04 (-0.45%)

16:46
10/19/18
10/19
16:46
10/19/18
16:46
Conference/Events
Epizyme to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.